Lysenyl, a new antiserotonin agent. Pharmacological and clinical survey.
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004873:Ergolines / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006213:Hallucinogens / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D051381:Rats; D012702:Serotonin Antagonists; D013270:Stomach / Q000187:drug effects; D013565:Sympatholytics / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use
D000959:Antihypertensive Agents; D004873:Ergolines; D006213:Hallucinogens; D012702:Serotonin Antagonists; D013565:Sympatholytics; D008238:Lysergic Acid Diethylamide; D014508:Urea